[{"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA214313"], "brand_name": ["NOREPINEPHRINE BITARTRATE"], "generic_name": ["NOREPINEPHRINE BITARTRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0108", "0338-0112", "0338-0116"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NOREPINEPHRINE BITARTRATE"], "rxcui": ["2475337", "2475340", "2619579"], "spl_id": ["c2f39b23-aa75-473c-951d-dee8ef00ab01"], "spl_set_id": ["6363e9b4-29df-4553-904d-a563e5adda6e"], "package_ndc": ["0338-0112-20", "0338-0108-20", "0338-0116-20"], "is_original_packager": [true], "unii": ["IFY5PE3ZRW"]}, "product_type": "Drugs", "event_id": "93843", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0336-2024", "product_description": "Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015.  Made in Ireland.  NDC:  0338-0108-20", "product_quantity": "13,000 bags", "reason_for_recall": "Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.", "recall_initiation_date": "20240123", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "Lot 23I21G64; Exp. 07/31/2024"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0094-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Capsules, Manufactured for : Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-851-01.", "product_quantity": "12,864 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #s 17222452, Exp. Date, 11/30/2024; 17230607, Exp. Date 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0383-2024", "product_description": "TRP Natural Eyes Red Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-158-15.", "product_quantity": "106,704 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: R608, Exp:04-21-2024, R609, Exp: 05-19-2024, R610, Exp: 07-28-2024, R611, Exp: 10-6-2024; R612, Exp: 02-02-2025, R613, Exp: 10-12-2025, R614, Exp: 11-02-2025"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["FENDALL 2000 PURE FLOW"], "generic_name": ["PURIFIED WATER"], "manufacturer_name": ["Honeywell Safety Products USA, Inc."], "product_ndc": ["0498-0631"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["WATER"], "rxcui": ["1053173"], "spl_id": ["0e4a17cb-beaf-6525-e063-6394a90a16b0"], "spl_set_id": ["b56ef662-fec2-4d94-e053-2995a90aba2b"], "package_ndc": ["0498-0631-37"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "94345", "recalling_firm": "HONEYWELL INC", "address_1": "855 S Mint St", "address_2": "N/A", "postal_code": "28202", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Canada", "recall_number": "D-0461-2024", "product_description": "Eyesaline, Saline Eyewash Solution, Cartridge for Fendall 2000, Net contents: 7.9 gal per cartridge, Sperian Eye & Face Protection, Inc., 825 East Highway 151, Platteville, WI 53818.  NDC:  0498-0631-37", "product_quantity": "10, 605 cartridges", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240329", "center_classification_date": "20240423", "termination_date": "20240930", "report_date": "20240501", "code_info": "Manufacturer's Product Number/ Catalog Number: 32-002050-0000; Exp 06/21/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0377-2024", "product_description": "TRP Eye Twitching Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-040-15.", "product_quantity": "9,936 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: C303, Exp: 07-27-2025"}, {"status": "Terminated", "city": "Bristol", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95715", "recalling_firm": "JR Watkins", "address_1": "400 Mill St Unit #D5", "address_2": "", "postal_code": "19007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0075-2025", "product_description": "Cooling Menthol Extra Strength Pain Relief Patch, Menthol 7.5%, packaged in box of 5, Distributed by J.R. Watkins LLC, Oakland CA 94612 UPC 8 56294 00878 5,  NDC 72342-100-05", "product_quantity": "7,138 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241101", "center_classification_date": "20241127", "termination_date": "20250916", "report_date": "20241204", "code_info": "Lot # JC101, JC102 and JC103, exp. date Oct 31, 2025", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204170"], "brand_name": ["ZOLPIDEM TARTRATE"], "generic_name": ["ZOLPIDEM TARTRATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-307", "47335-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZOLPIDEM TARTRATE"], "rxcui": ["854880", "854894"], "spl_id": ["4a5c474b-e752-4d01-be37-a66e7c9bf62e"], "spl_set_id": ["0c64bc71-2e7f-4b15-a8e1-acb8de04395f"], "package_ndc": ["47335-307-88", "47335-307-13", "47335-308-88", "47335-308-13"], "is_original_packager": [true], "upc": ["0347335307887", "0347335308884"], "unii": ["WY6W63843K"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0271-2024", "product_description": "Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-307-88.", "product_quantity": "1220 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0892A Exp. 07/31/2026"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0409-2024", "product_description": "HYDROmorphone HCl 30 mg/30mL in 0.9% Sodium Chloride Injection, (Concentration = 1 mg/ml) 30 mL fill 35 mL Plungerless Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-16, Bar Code 70004030316", "product_quantity": "5392 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048357 Exp 11/15/23; 1223048461 EXP 11/20/23; 1223048486 EXP 11/21/23; 1223048694 EXP  12/01/23; 1223048865 EXP  12/06/23; 1223048967 EXP  12/11/23; 1223049098 EXP  12/15/23; 1223049133 EXP 12/19/23; 1223049175 EXP  12/20/23; 1223049268 EXP  12/25/23; 1223049457 EXP 01/01/24; 1223049561 EXP  01/04/24; 1223049604 EXP  01/05/24; 1223049648 EXP  01/09/24; 1223049870 EXP  01/17/24; 1223049942 EXP  01/19/24; 1223049973 EXP 01/23/24; 1223050060 EXP  01/25/24;", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202868"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-357"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312504"], "spl_id": ["b0251572-aa7f-434a-a7ff-33ccbc37dfaf"], "spl_set_id": ["5b054142-7372-4641-be27-dca630a97ad9"], "package_ndc": ["68462-357-90", "68462-357-01", "68462-357-05"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "94715", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0607-2024", "product_description": "Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-05", "product_quantity": "", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240530", "center_classification_date": "20240717", "report_date": "20240724", "code_info": "Lot #: 17230186, 17230192, 17230213, 17230278, 17230399, Exp Dec-31-24; 17230406, 17230412, 17230427, 17230444, 17230453, 17230495, Exp Jan-31-25; 17230574, 17230585, 17230608, 17230629, Exp Feb-28-25; 17230883, 17230921, Exp Mar-31-25; 17231087, 17231339, Exp Apr-30-25; 17231360, Exp May-31-25; 17231711, 17231745, Exp Jun-30-25; 17231819, 17231820, 17231936, 17231957, Exp Jul-31-25; 17231998, 17232012, Aug-31-25; 17232110, Exp Sep-30-25; 17232114, Exp Aug-31-25; 17232119, 17232343, Exp Sep-30-25.", "more_code_info": ""}, {"status": "Terminated", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "94945", "recalling_firm": "Endo Pharmaceuticals, Inc.", "address_1": "1400 Atwater Dr", "address_2": "N/A", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0622-2024", "product_description": "Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.", "product_quantity": "8,139 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.", "recall_initiation_date": "20240710", "center_classification_date": "20240730", "termination_date": "20250916", "report_date": "20240807", "code_info": "Lot 550147301, Exp. 08/31/2026"}, {"status": "Ongoing", "city": "Rangareddy", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93868", "recalling_firm": "NATCO Pharma Limited", "address_1": "Pharma Division, Kothur Village", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0318-2024", "product_description": "Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41", "product_quantity": "4260 bottles", "reason_for_recall": "CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.", "recall_initiation_date": "20240201", "center_classification_date": "20240208", "report_date": "20240214", "code_info": "Lot # 411987 Exp:  05/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0415-2024", "product_description": "PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 5 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-11, Bar Code 70004081011", "product_quantity": "7,198 syringes; expanded 1,289 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223045053 Exp 11/15/23; 1223046179 Exp 12/28/23; 1223047477 Exp 02/16/24; 1223047602 Exp 02/22/24; 1223047971 Exp 03/14/24; 1223048269 Exp 03/27/24  Expanded lot#: 1223048181, exp. date 03/22/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["GLOSTRIPS"], "generic_name": ["FLUORESCEIN SODIUM"], "manufacturer_name": ["Nomax Inc."], "product_ndc": ["51801-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["FLUORESCEIN SODIUM"], "spl_id": ["be8f6626-961d-48c3-ba7f-a2fae87c4cb6"], "spl_set_id": ["d06a4432-c76c-4e2a-abec-6bc5b4e82d51"], "package_ndc": ["51801-009-50", "51801-009-40"], "is_original_packager": [true], "unii": ["93X55PE38X"]}, "product_type": "Drugs", "event_id": "94461", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0463-2024", "product_description": "GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40.", "product_quantity": "6,960 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.", "recall_initiation_date": "20240419", "center_classification_date": "20240423", "report_date": "20240501", "code_info": "Lot #: 14708, Exp. 04/30/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["60429-164", "60429-165", "60429-166"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["3a8cefd0-9db7-8cd0-e063-6394a90a5996"], "spl_set_id": ["f535fcd2-a50a-4423-85d9-705fd2d9a470"], "package_ndc": ["60429-164-60", "60429-165-30", "60429-165-90", "60429-166-30", "60429-166-10"], "original_packager_product_ndc": ["51991-746", "51991-747", "51991-748"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "94639", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0568-2024", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottles, NDC 60429-165-90, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Packaged by GSMS, Incorporated, Camarillo, CA 93012.", "product_quantity": "21,655 (30 count bottle), 34,149 (90 count bottle)", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.", "recall_initiation_date": "20240513", "center_classification_date": "20240625", "termination_date": "20250320", "report_date": "20240703", "code_info": "Lot: a) GS045371, Exp: 01/31/2025; b) GS045910, Exp. 01/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Charleston", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94447", "recalling_firm": "EPI Health, LLC", "address_1": "174 Meeting St Ste 200", "address_2": "N/A", "postal_code": "29401-3211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0473-2024", "product_description": "Cloderm (clocortolone pivalate) Cream, 0.1%, Rx Only, For Topical Use Only, Net Wt 45g, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-804-90", "product_quantity": "18645 tubes", "reason_for_recall": "CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.", "recall_initiation_date": "20240423", "center_classification_date": "20240425", "termination_date": "20240912", "report_date": "20240501", "code_info": "lot SDFC- exp. 5/31/2024 lot TFBW- exp. 5/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206799"], "brand_name": ["VORICONAZOLE"], "generic_name": ["VORICONAZOLE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-038"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VORICONAZOLE"], "rxcui": ["465355"], "spl_id": ["9b8865b7-cdc3-4505-b9ba-b3ab1bf909d6"], "spl_set_id": ["e37525e8-afb4-4583-b2de-af4aab9040d7"], "package_ndc": ["43386-038-60"], "is_original_packager": [true], "nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["JFU09I87TR"]}, "product_type": "Drugs", "event_id": "93934", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "OH, IL, NJ", "recall_number": "D-0337-2024", "product_description": "Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.", "product_quantity": "N/A", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert", "recall_initiation_date": "20240205", "center_classification_date": "20240216", "termination_date": "20241227", "report_date": "20240228", "code_info": "Lot#: S200756; Exp. 10/2024 Lot#: S300218; Exp. 04/2025 Lot#: S300633; Exp. 09/2025"}, {"status": "Completed", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090534"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Civica, Inc."], "product_ndc": ["72572-470"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["fba70df6-5d37-4a12-bce3-e6fb1b0c72b2"], "spl_set_id": ["30fb3a4d-fa75-42fd-b4b6-2a21f202027f"], "package_ndc": ["72572-470-01", "72572-470-10"], "is_original_packager": [true], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "94621", "recalling_firm": "American Regent, Inc.", "address_1": "6610 New Albany Rd E", "address_2": "", "postal_code": "43054-8730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "UT only", "recall_number": "D-0503-2024", "product_description": "niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054.  NDC 72572-470-10", "product_quantity": "4,136 cartons (10 vials in each carton)", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20240514", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot #: 23087N0C0, Exp. Date 11/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0306-2024", "product_description": "Lubricant Gel Drops (Carboxymethylcellulose sodium 1.0%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-4540-5", "product_quantity": "7,200 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA211746"], "brand_name": ["RYALTRIS"], "generic_name": ["OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE"], "manufacturer_name": ["HIKMA SPECIALTY USA INC."], "product_ndc": ["59467-700"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["MOMETASONE FUROATE MONOHYDRATE", "OLOPATADINE HYDROCHLORIDE"], "rxcui": ["2591806", "2591812"], "spl_id": ["b14c6f4f-8765-4436-8cc8-1e913f05a542"], "spl_set_id": ["382eac74-a7ce-4f42-ac0a-b253308f335f"], "package_ndc": ["59467-700-27", "59467-700-84"], "is_original_packager": [true], "upc": ["0359467700276"], "unii": ["MTW0WEG809", "2XG66W44KF"]}, "product_type": "Drugs", "event_id": "95389", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0006-2025", "product_description": "Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.", "product_quantity": "45,504 bottles", "reason_for_recall": "Defective Delivery System: The dip tube is clogged causing the spray not to work.", "recall_initiation_date": "20240924", "center_classification_date": "20241003", "report_date": "20241009", "code_info": "Lots 14230425, Exp Date, Nov-25; 14240024, Exp Date Dec-25; 14240029, Exp Date Dec-25; 14240076, Exp Date Jan-26; 14240082 Exp Date, Jan-26, 14240090, Exp Date Jan-26; and 14240100, Exp Date Jan-26"}, {"status": "Ongoing", "city": "Atlanta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94949", "recalling_firm": "Supercore Products Group Inc.", "address_1": "230 Peachtree St Nw", "address_2": "Ste 2200", "postal_code": "30303-1534", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide US (2014), Israel (2), Canada (12), Republic of Kosovo (1), Pakistan (1), Australia (3), Morocco (1), United Kingdom (1)", "recall_number": "D-0003-2025", "product_description": "Hard Steel Capsules packaged in 1 count blister packs in boxes of 10, 20 and 30, Manufactured in U.S.A.", "product_quantity": "729", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.", "recall_initiation_date": "20240712", "center_classification_date": "20241002", "report_date": "20241009", "code_info": "All lots"}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["STELLALIFE VEGA ORAL CARE"], "generic_name": ["ARNICA, CALENDULA, CHAMOMILLA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, HEPAR SULPH CALC, HYPERICUM, LGNATIA, RUTA, STAPHYSAGRIA"], "manufacturer_name": ["StellaLife, Inc."], "product_ndc": ["69685-121"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ARNICA MONTANA", "CALCIUM SULFIDE", "CALENDULA OFFICINALIS FLOWERING TOP", "DELPHINIUM STAPHISAGRIA SEED", "ECHINACEA ANGUSTIFOLIA", "ECHINACEA PURPUREA", "HYPERICUM PERFORATUM", "LEDUM PALUSTRE TWIG", "MATRICARIA RECUTITA", "RUTA GRAVEOLENS FLOWERING TOP", "SILICON DIOXIDE", "STRYCHNOS IGNATII SEED"], "spl_id": ["173cb04b-d3ac-af3f-e063-6294a90ab4ab"], "spl_set_id": ["10f8dee1-d5d3-0602-e063-6294a90a6dbf"], "package_ndc": ["69685-121-01"], "is_original_packager": [true], "unii": ["O80TY208ZW", "1MBW07J51Q", "18E7415PXQ", "00543AP1JV", "VB06AV5US8", "QI7G114Y98", "XK4IUX8MNB", "877L01IZ0P", "G0R4UBI2ZZ", "N94C2U587S", "ETJ7Z6XBU4", "1NM3M2487K"]}, "product_type": "Drugs", "event_id": "94782", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide to 60 Physician offices", "recall_number": "D-0609-2024", "product_description": "STELLALIFE VEGA Oral Care, Spray, Unflavored, 1 fl oz (30 ml) bottles, Distributed by: StellaLife, 22875 NE 191 Street, Suite 500, Aventura, FL 33180, NDC 69685-121-01", "product_quantity": "31,811 x 1 fl. oz. spray bottle", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: multiple Bacillus species organisms", "recall_initiation_date": "20240605", "center_classification_date": "20240717", "termination_date": "20241113", "report_date": "20240724", "code_info": "Lot # 2552, exp. date 02-28-2026", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206127"], "brand_name": ["EPTIFIBATIDE"], "generic_name": ["EPTIFIBATIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-218", "55150-219", "55150-220"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["EPTIFIBATIDE"], "rxcui": ["200349", "1736470", "1736477"], "spl_id": ["944b269c-d810-411d-9ed4-8edd9d0ac1b7"], "spl_set_id": ["00ad7bbe-cadd-4647-b74b-adfc9f2b5e94"], "package_ndc": ["55150-218-99", "55150-219-10", "55150-220-99"], "is_original_packager": [true], "upc": ["0355150220991", "0355150219100"], "nui": ["N0000008832", "N0000175578"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Platelet Aggregation Inhibitor [EPC]"], "unii": ["NA8320J834"]}, "product_type": "Drugs", "event_id": "94680", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0556-2024", "product_description": "Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10", "product_quantity": "15,500 single dose vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.", "recall_initiation_date": "20240522", "center_classification_date": "20240614", "report_date": "20240626", "code_info": "Lot #: 3EF22003, Exp 6/30/2025"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210040"], "brand_name": ["METHOTREXATE"], "generic_name": ["METHOTREXATE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHOTREXATE SODIUM"], "rxcui": ["105585"], "spl_id": ["efc08af1-49d5-4361-81ab-0d23e19d3f4c"], "spl_set_id": ["dd39255b-81d1-4c08-aecf-acc4f2cdc04a"], "package_ndc": ["69238-1423-6", "69238-1423-1"], "is_original_packager": [true], "unii": ["3IG1E710ZN"]}, "product_type": "Drugs", "event_id": "95082", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0629-2024", "product_description": "Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1", "product_quantity": "12,624 bottles", "reason_for_recall": "Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.", "recall_initiation_date": "20240801", "center_classification_date": "20240808", "report_date": "20240814", "code_info": "Lot # BB29124, Exp. 02/28/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Bennet", "state": "NE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95503", "recalling_firm": "Staska Pharmaceuticals, Inc.", "address_1": "742 Evergreen Dr", "address_2": "N/A", "postal_code": "68317-2365", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0040-2025", "product_description": "Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317", "product_quantity": "4773 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of glass particulates.", "recall_initiation_date": "20240930", "center_classification_date": "20241107", "termination_date": "20250805", "report_date": "20241113", "code_info": "Lot #SP2400058, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94461", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0464-2024", "product_description": "FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.", "product_quantity": "4648 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.", "recall_initiation_date": "20240419", "center_classification_date": "20240423", "report_date": "20240501", "code_info": "Lot 14842, Exp. 6/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125387"], "brand_name": ["EYLEA"], "generic_name": ["AFLIBERCEPT"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "product_ndc": ["61755-005"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVITREAL"], "substance_name": ["AFLIBERCEPT"], "rxcui": ["1232154", "1232159", "2693564", "2693567"], "spl_id": ["10b670d6-52e0-4eba-953b-c839ffb98014"], "spl_set_id": ["f96cfd69-da34-41ee-90a9-610a4655cd1c"], "package_ndc": ["61755-005-02", "61755-005-55", "61755-005-01", "61755-005-54", "8231500321", "8231500335", "8231500333", "8231500334", "8231500339", "8231500347"], "is_original_packager": [true], "nui": ["N0000193543", "N0000193542"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "unii": ["15C2VL427D"]}, "product_type": "Drugs", "event_id": "94481", "recalling_firm": "Regeneron Pharmaceuticals Inc", "address_1": "777 Old Saw Mill River Rd", "address_2": "", "postal_code": "10591-6717", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0479-2024", "product_description": "EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01", "product_quantity": "251,504 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Complaints of syringe breakage", "recall_initiation_date": "20240423", "center_classification_date": "20240502", "termination_date": "20250925", "report_date": "20240508", "code_info": "Lot # 8231500321, Exp 10/31 24; 8231500335, 8231500333, 8231500334, 8231500339, 8231500347, Exp 1/30/25", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0520-2024", "product_description": "Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%),  Enriched with Capsaicin, Camphor, Menthol & MSM, Bottle with pump, NET WT 16 fluid oz / 473.17 ml, Made in USA, www.painwizard.com  Pain Wizard LLC.PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00012 3", "product_quantity": "3,440", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot: 18723C3, Exp 06/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040597"], "brand_name": ["BENZONATATE"], "generic_name": ["BENZONATATE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-214"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BENZONATATE"], "rxcui": ["197397"], "spl_id": ["235a2641-ce68-1f9c-e063-6394a90ac8a7"], "spl_set_id": ["9a71725a-64b6-4800-a79c-aa4b2d74d44f"], "package_ndc": ["68084-214-11", "68084-214-01"], "original_packager_product_ndc": ["68382-247"], "nui": ["N0000009010", "N0000175796"], "pharm_class_pe": ["Decreased Tracheobronchial Stretch Receptor Activity [PE]"], "pharm_class_epc": ["Non-narcotic Antitussive [EPC]"], "unii": ["5P4DHS6ENR"]}, "product_type": "Drugs", "event_id": "93778", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0257-2024", "product_description": "Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11", "product_quantity": "6,344 cartons", "reason_for_recall": "Superpotent drug: Assay results were slightly above specification at the time zero point.", "recall_initiation_date": "20231226", "center_classification_date": "20240119", "report_date": "20240131", "code_info": "Lot # 1014208, Exp Mar/31/2025"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["WALGREEN COMPANY"], "product_ndc": ["0363-0427"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["29f8e1fc-be2e-b603-e063-6394a90a7673"], "spl_set_id": ["effad954-b70d-d8e6-e053-2a95a90acaf7"], "package_ndc": ["0363-0427-98"], "is_original_packager": [true], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0228-2024", "product_description": "Walgreens Dye-Free Magnesium Citrate Saline Laxative/Oral Solution, Sugar Free Low Sodium, Grape flavor 10 fl. oz, Distributed by: Walgreen Co, 200 Wilmot Rd, Deerfield, IL 60015, NDC 0363-0427-98.", "product_quantity": "49,716 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lot A80623; Exp. 11/30/2025"}, {"status": "Completed", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021849"], "brand_name": ["OMEPRAZOLE AND SODIUM BICARBONATE"], "generic_name": ["OMEPRAZOLE, SODIUM BICARBONATE"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "product_ndc": ["68682-102", "68682-990", "68682-991", "68682-104"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OMEPRAZOLE", "SODIUM BICARBONATE"], "rxcui": ["616539", "616541", "753557", "753562"], "spl_id": ["342c0d17-867e-d8da-e063-6394a90a3151"], "spl_set_id": ["c26b6893-8264-4d4a-ac7e-1ddda933451e"], "package_ndc": ["68682-990-30", "68682-991-30", "68682-102-30", "68682-104-30"], "is_original_packager": [true], "upc": ["0368682102307", "0368682104301"], "nui": ["N0000175525", "N0000000147", "N0000182140"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["KG60484QX9", "8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "93911", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0355-2024", "product_description": "Omeprazole and Sodium Bicarbonate For Oral Suspension  40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.", "product_quantity": "3,600 cartons", "reason_for_recall": "Subpotent Drug: Out of specification for assay", "recall_initiation_date": "20240202", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #0013R; Exp. 01/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0169-2024", "product_description": "Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Doses, Rx only, Manufactured for: Organon LLC, a subsidiary of Organon & Co., Jersey City, NJ 07302; Manufactured by: MSD International GmbH (Singapore Branch) Singapore 638030, Singapore. NDC: 78206-114-01", "product_quantity": "3 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch U027458", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0523-2024", "product_description": "ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%),  Original Formula, SPF 40+, Broad Spectrum Protective Gel, Sport Performance, NET WT 1 OZ (28 g), Manufactured for AGS Brands.", "product_quantity": "4,013", "reason_for_recall": "Out of Specification for active ingredient", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 04023C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA215307"], "brand_name": ["DIGOXIN"], "generic_name": ["DIGOXIN"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["70954-200", "70954-201", "70954-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIGOXIN"], "rxcui": ["197604", "197606", "245273"], "spl_id": ["ee465d1a-f5ee-477b-b20e-3ce8705e7472"], "spl_set_id": ["dba3b3f7-3ff2-4996-8653-b0e54a398bf9"], "package_ndc": ["70954-201-10", "70954-201-20", "70954-202-10", "70954-202-20", "70954-200-10"], "is_original_packager": [true], "upc": ["0370954201106", "0370954201205", "0370954202103", "0370954200109"], "nui": ["N0000175568", "M0003451"], "pharm_class_epc": ["Cardiac Glycoside [EPC]"], "pharm_class_cs": ["Cardiac Glycosides [CS]"], "unii": ["73K4184T59"]}, "product_type": "Drugs", "event_id": "94132", "recalling_firm": "Novitium Pharma LLC", "address_1": "70 Lake Dr", "address_2": "", "postal_code": "08520-5321", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0389-2024", "product_description": "Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20", "product_quantity": "3,940 1000-count bottles", "reason_for_recall": "Cross Contamination with Other Products:(mycophenolate mofetil).", "recall_initiation_date": "20240304", "center_classification_date": "20240315", "termination_date": "20250321", "report_date": "20240327", "code_info": "Lot #: M23172A, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0530-2024", "product_description": "ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%), SPF 40+, Broad Spectrum Protective Gel, Sport Performance, NET WT 4 OZ (113g), Manufactured for AGS Brands. UPC 0 17971 10421 7", "product_quantity": "6,264", "reason_for_recall": "Out of Specification for active ingredient", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 04023C1 Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Vaudreuil-Dorion", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["M020"], "brand_name": ["SHEET SPF 30 MINERAL"], "generic_name": ["TITANIUM DIOXIDE, ZINC OXIDE"], "manufacturer_name": ["Vivier Pharma Inc."], "product_ndc": ["67226-2232"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TITANIUM DIOXIDE", "ZINC OXIDE"], "spl_id": ["1159e6f6-423b-51ac-e063-6394a90ab0a4"], "spl_set_id": ["bbb5b87c-d641-3ba2-e053-2a95a90a0f70"], "package_ndc": ["67226-2232-6"], "is_original_packager": [true], "upc": ["0696163800337"], "unii": ["15FIX9V2JP", "SOI2LOH54Z"]}, "product_type": "Drugs", "event_id": "95339", "recalling_firm": "Vivier Pharma, Inc.", "address_1": "288 Adrien-Patenaude St", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0662-2024", "product_description": "Vivier Sheer SPF 30 Mineral With Antioxidants (titanium dioxide 10% and zinc oxide 8%) packaged in 60 ml/2 fl oz, Vivier Canada Inc. / Mfd. for Vivier Pharma, Vaudereull-Dorion OC Canada, J7V 5V5, Champlain, NY USA 12919, Made in Canada, NDC 67226-2232-6. SKU 10-160-ZZ-80059-R", "product_quantity": "3476 units", "reason_for_recall": "Microbial Contamination of Non-Sterile Product", "recall_initiation_date": "20240903", "center_classification_date": "20240920", "report_date": "20241002", "code_info": "Lot #: 91771, Exp. Date 09/2025", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091567"], "brand_name": ["FEXOFENADINE HYDROCHLORIDE"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["OHM LABORATORIES INC.", "CVS PHARMACY, INC"], "product_ndc": ["51660-998", "51316-800"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["091c0633-b5d5-462a-8aa0-36ae245dbbbc", "e6bae65e-9f41-4976-bebd-c14e86da14cb"], "spl_set_id": ["1a1afa95-570d-456e-b436-a0fcfaf68517", "7bc13851-291a-4582-8261-13c5022fbdd1"], "package_ndc": ["51660-998-30", "51660-998-55", "51316-800-90", "51316-800-70", "51316-800-45", "51316-800-30", "51316-800-15", "51316-800-08"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0273-2024", "product_description": "Fexofenadine Hydrochloride Tablets, USP 180mg, Antihistamine, Allergy, 24 hour, a) 30 Tablets per bottle, NDC 51660-998-30; Distributed by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Made in India, b) 45 Tablets per bottle, NDC 51316-800-45; Distributed by: CVS Pharmacy, Inc., Woonsocket, RI 02895, Made in India, c) 150 Tablets per bottle, NDC 51660-998-55, Distributed by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Made in India.", "product_quantity": "54,504 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s:  a) DNE0792A Exp. 06/31/2025; DNE1027A Exp. 08/31/2025. b) DNE0793A Exp. 06/31/2025. c) DNE0789A, DNE0790A, DNE0791A Exp. 06/2025, DNE1026A Exp. 08/31/025."}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M013"], "brand_name": ["MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK"], "generic_name": ["DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE"], "manufacturer_name": ["Genexa Inc."], "product_ndc": ["69676-0079"], "product_type": ["HUMAN OTC DRUG"], "rxcui": ["2692302", "2692303", "2692304"], "spl_id": ["38f8afad-542e-ae0c-e063-6294a90a243f"], "spl_set_id": ["18835205-a9e3-15c2-e063-6394a90a8107"], "package_ndc": ["69676-0079-3", "69676-0077-9", "69676-0094-9", "8500157360"], "is_original_packager": [true], "upc": ["850015736018"]}, "product_type": "Drugs", "event_id": "95430", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts that may have distributed the product further to the Retail Level.", "recall_number": "D-0034-2025", "product_description": "Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg), packaged in 4 oz bottles further packaged in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code# 850015736018", "product_quantity": "105,048 bottles", "reason_for_recall": "Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.", "recall_initiation_date": "20240925", "center_classification_date": "20241101", "report_date": "20241113", "code_info": "Lot#: 0813V, Exp 06/2025; 0103V, Exp 03/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Exton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95190", "recalling_firm": "ProRx LLC", "address_1": "619 Jeffers Cir", "address_2": "", "postal_code": "19341-2540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0655-2024", "product_description": "TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only,  2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01", "product_quantity": "1,489 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240822", "center_classification_date": "20240905", "report_date": "20240911", "code_info": "Lot #  ProRx051424, BUD 11/13/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "95921", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one Us Distributor in NJ.", "recall_number": "D-0114-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-513-15.", "product_quantity": "5184 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20241205", "center_classification_date": "20241206", "report_date": "20241218", "code_info": "Lot #: 083I006, Exp 08/31/2025", "more_code_info": ""}, {"status": "Completed", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93928", "recalling_firm": "Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana.", "recall_number": "D-0346-2024", "product_description": "TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591 UPC 3 63736 81961 3", "product_quantity": "59,644 cans", "reason_for_recall": "Chemical Contamination; presence of benzene.", "recall_initiation_date": "20240201", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "Lot #  0H50545, Exp. date 07/31/24; 1G50645, Exp. date 06/30/25"}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93808", "recalling_firm": "Neptune Resources, LLC", "address_1": "1324 W 12th St Fl 5", "address_2": "N/A", "postal_code": "64101-1343", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0333-2024", "product_description": "Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl oz (10 mL) bottle, Distributed By Neptune Resources, LLC, 30 N. Gould Street, Ste R, Sheridan, WY 82801.", "product_quantity": "1,000,000 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240112", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "All lots"}, {"status": "Ongoing", "city": "High Ridge", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94366", "recalling_firm": "Integrity Products", "address_1": "5613 Park Road Suite 2", "address_2": "N/A", "postal_code": "63049", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0585-2024", "product_description": "RAM IT, Horny Goat Weed, dietary supplement capsules, 1000 mg, packaged in a box containing a 10-count blister card, Distributed By: Integrity Products, 1710 Fenpark Dr., Fenton, MO 63026", "product_quantity": "2500 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.", "recall_initiation_date": "20240201", "center_classification_date": "20240703", "report_date": "20240710", "code_info": "Lot HGW221116 (Batch 020123-1), Exp 5/31/2025"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA086242"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905199"], "spl_id": ["13a2cf75-5816-2d86-e063-6394a90a0cc2"], "spl_set_id": ["53908945-540f-4d34-8f0a-b4a87676634e"], "package_ndc": ["68084-447-11", "68084-447-01"], "original_packager_product_ndc": ["23155-001"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "93936", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0320-2024", "product_description": "HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 68084-447-01;  NDC Unit Dose: 68084-447-11", "product_quantity": "2,850 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.", "recall_initiation_date": "20240201", "center_classification_date": "20240208", "report_date": "20240214", "code_info": "Lot #: 1012275, Exp 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091024"], "brand_name": ["ESZOPICLONE"], "generic_name": ["ESZOPICLONE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-617", "55111-629", "55111-619"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESZOPICLONE"], "rxcui": ["485440", "485442", "485465"], "spl_id": ["bf1433f5-bde8-8c67-9ff7-ec5d3ed26581"], "spl_set_id": ["0b363b90-93dc-1fc1-0501-d140dfc762c7"], "package_ndc": ["55111-629-30", "55111-629-01", "55111-629-05", "55111-619-30", "55111-619-90", "55111-619-01", "55111-619-05", "55111-619-79", "55111-619-09", "55111-617-30", "55111-617-90", "55111-617-01", "55111-617-05", "55111-617-79", "55111-617-09"], "is_original_packager": [true], "upc": ["0355111617013", "0355111629306", "0355111619017"], "unii": ["UZX80K71OE"]}, "product_type": "Drugs", "event_id": "94754", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "OH, MS", "recall_number": "D-0581-2024", "product_description": "Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30", "product_quantity": "13,752 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Related Substances", "recall_initiation_date": "20240604", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "Lot#: C2302598, Exp 2/29/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "94440", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0472-2024", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.", "product_quantity": "3,264 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240417", "center_classification_date": "20240425", "report_date": "20240501", "code_info": "Lot #: 17221312, Exp. 5/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0063-2025", "product_description": "ABSORBINE jr ULTRA STRENGTH PAIN PATCH, Menthol 6.5%, 1 patch per box, Distributed By: Absorbine Jr. LLC, Chattanooga, TN 37402 UPC 8 89476 41318 3, UPC 8 89476 41336 7", "product_quantity": "4,968,000 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 89476 41318 3, UPC 8 89476 41336 7", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["DRY EYE RELIEF"], "generic_name": ["POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0088"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYETHYLENE GLYCOL 400", "PROPYLENE GLYCOL"], "rxcui": ["895753"], "spl_id": ["424cccfb-27a9-43c8-9793-34bc5ddcb882"], "spl_set_id": ["f8da3af5-9172-4023-be82-0fd5bd891616"], "package_ndc": ["70000-0088-1"], "is_original_packager": [true], "unii": ["B697894SGQ", "6DC9Q167V3"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0295-2024", "product_description": "Leader brand Dry Eye Relief (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) packaged in 0.33 FL OZ (10 mL) bottles, Distributed by Cardinal Health Dublin, Ohio 43017, NDC 70000-0088-1", "product_quantity": "12,960 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0376-2024", "product_description": "TRP Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-002-11.", "product_quantity": "7,248 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: B905, Exp: 07-13-2025"}, {"status": "Ongoing", "city": "High Ridge", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94366", "recalling_firm": "Integrity Products", "address_1": "5613 Park Road Suite 2", "address_2": "N/A", "postal_code": "63049", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0586-2024", "product_description": "To the Moon Capsules, Horny Goat Weed, 1000 mg, packaged in a box containing a 10-count blister card,  Distributed By: Integrity Products, 1710 Fenpark Dr., Fenton, MO 63026", "product_quantity": "2500 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.", "recall_initiation_date": "20240201", "center_classification_date": "20240703", "report_date": "20240710", "code_info": "Lot HGW221116 (Batch 022123-1), Exp 5/31/2025"}, {"status": "Ongoing", "city": "Fort Mill", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95587", "recalling_firm": "Trinity Gold Nutrition", "address_1": "201 Tom Hall St", "address_2": "STE 2107", "postal_code": "29715-2313", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States; additionally Canada, England, and Australia.", "recall_number": "D-0042-2025", "product_description": "Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009", "product_quantity": "150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.", "recall_initiation_date": "20241106", "center_classification_date": "20241112", "report_date": "20241120", "code_info": "Lot #: IN-030, Exp. Date: NOV 2027"}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA202862"], "brand_name": ["OLANZAPINE"], "generic_name": ["OLANZAPINE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-067", "33342-068", "33342-069", "33342-070", "33342-071", "33342-072"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLANZAPINE"], "rxcui": ["200034", "283639", "312077", "312078", "312079", "314154"], "spl_id": ["3cb20bd0-3dd5-4742-b2d6-bfbeb8878d31"], "spl_set_id": ["8e095987-bdea-42f2-9550-c7155cf07d30"], "package_ndc": ["33342-067-07", "33342-067-44", "33342-067-12", "33342-067-11", "33342-068-07", "33342-068-44", "33342-068-12", "33342-068-11", "33342-069-07", "33342-069-44", "33342-069-12", "33342-069-11", "33342-070-07", "33342-070-15", "33342-070-12", "33342-070-44", "33342-070-11", "33342-071-07", "33342-071-15", "33342-071-12", "33342-071-44", "33342-071-11", "33342-072-07", "33342-072-15", "33342-072-12", "33342-072-44", "33342-072-11"], "is_original_packager": [true], "upc": ["0333342067074", "0333342070074", "0333342069078", "0333342072078", "0333342071071", "0333342068071"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["N7U69T4SZR"]}, "product_type": "Drugs", "event_id": "95838", "recalling_firm": "Macleods Pharmaceuticals Ltd", "address_1": "304 Atlanta Arcade", "address_2": "Church Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0154-2025", "product_description": "Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.", "product_quantity": "15,744 30-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20241125", "center_classification_date": "20241219", "report_date": "20241225", "code_info": "Lot# BOB12318A Exp 07/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0071-2025", "product_description": "CHEEKY BONSAI PAIN RELIEF PATCHES, Menthol 10%, 4 patches per box, Distributed by Cheeky Bonsai, San Francisco, CA UPC 8 60006 57564 9", "product_quantity": "17,928 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 60006 57564 9", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "95027", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. A. Nationwide", "recall_number": "D-0623-2024", "product_description": "Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.", "product_quantity": "66,528 bottles", "reason_for_recall": "Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20240723", "center_classification_date": "20240801", "report_date": "20240807", "code_info": "Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206125"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-831", "65862-832", "65862-833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6"], "spl_set_id": ["42e99112-c402-4662-877f-9e3a84dff9f2"], "package_ndc": ["65862-831-30", "65862-831-90", "65862-831-01", "65862-831-05", "65862-832-30", "65862-832-90", "65862-832-01", "65862-832-05", "65862-833-30", "65862-833-90", "65862-833-01", "65862-833-05"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95730", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0079-2025", "product_description": "Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.  90 mg - 30 Tablets - NDC 65862-833-30 90 mg - 500 Tablets - NDC 65862-833-05", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241107", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: a) CFSC23001A, CFSC23001B, Exp 03/31/2025; b) P2300195, Exp 12/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204629"], "brand_name": ["JARDIANCE"], "generic_name": ["EMPAGLIFLOZIN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0152", "0597-0153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN"], "rxcui": ["1545658", "1545664", "1545666", "1545668"], "spl_id": ["2669be16-3d07-4426-a711-aac76ce3d3c9"], "spl_set_id": ["faf3dd6a-9cd0-39c2-0d2e-232cb3f67565"], "package_ndc": ["0597-0152-90", "0597-0152-07", "0597-0152-70", "0597-0152-37", "0597-0152-30", "0597-0153-37", "0597-0153-30", "0597-0153-90", "0597-0153-07", "0597-0153-70"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0185-2024", "product_description": "Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.  NDC: 0597-0153-37", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch D41919", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077042"], "brand_name": ["CITALOPRAM"], "generic_name": ["CITALOPRAM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6231", "0378-6232", "0378-6233"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CITALOPRAM HYDROBROMIDE"], "rxcui": ["200371", "283672", "309314"], "spl_id": ["55e0b75b-3772-4f5b-a162-1f70719daf3d"], "spl_set_id": ["825c0c49-5fbf-6d8b-cb8c-94ebf0eda043"], "package_ndc": ["0378-6231-01", "0378-6231-05", "0378-6232-01", "0378-6232-05", "0378-6233-01", "0378-6233-05"], "is_original_packager": [true], "upc": ["0303786232017", "0303786231010", "0303786233014"], "unii": ["I1E9D14F36"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0173-2024", "product_description": "CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 0378-6232-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3131748", "more_code_info": ""}, {"status": "Terminated", "city": "Verna", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA207016"], "brand_name": ["TELMISARTAN"], "generic_name": ["TELMISARTAN"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-226", "42571-227", "42571-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TELMISARTAN"], "rxcui": ["205304", "205305", "282755"], "spl_id": ["f2aa8284-f86c-3425-e053-2995a90a6dc6"], "spl_set_id": ["d7c9bd41-9558-46e1-ab03-82cdf85db3fe"], "package_ndc": ["42571-226-30", "42571-226-90", "42571-226-05", "42571-226-10", "42571-226-32", "42571-226-11", "42571-226-41", "42571-227-30", "42571-227-90", "42571-227-05", "42571-227-10", "42571-227-32", "42571-227-11", "42571-227-41", "42571-228-30", "42571-228-90", "42571-228-05", "42571-228-10", "42571-228-32", "42571-228-11", "42571-228-41"], "is_original_packager": [true], "upc": ["0342571228309", "0342571226305", "0342571227302"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "93965", "recalling_firm": "Micro Labs Limited", "address_1": "Plot# S - 155", "address_2": "& N1 Phase Iii & Phase Iv; Verna Ind Estate Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico, TN, RI", "recall_number": "D-0388-2024", "product_description": "Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.", "product_quantity": "118,080 bottles", "reason_for_recall": "Failed Stability Specifications: Out of specification for blend uniformity.", "recall_initiation_date": "20240209", "center_classification_date": "20240314", "termination_date": "20250624", "report_date": "20240320", "code_info": "Lot #s: SFBG024, SFBG025, Exp. 05/31/2024"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94750", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0561-2024", "product_description": "Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34", "product_quantity": "34,448 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240604", "center_classification_date": "20240618", "report_date": "20240626", "code_info": "Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95304", "recalling_firm": "Empower Pharmacy", "address_1": "5980 W Sam Houston Pkwy N Ste 300", "address_2": "", "postal_code": "77041-5254", "voluntary_mandated": "", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0663-2024", "product_description": "Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use only, RX Only, Compounded by: Empower Pharmacy 5980 W Sam Houston Pkwy N Ste 300, Houston, TX 77041 NDC 72627-2424-1.", "product_quantity": "450", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240905", "center_classification_date": "20240920", "termination_date": "20250214", "report_date": "20241002", "code_info": "Product lot number: 609763 Beyond Use Date: 04/18/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0454-2024", "product_description": "libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box,  UPC 7 05105 83073 5.", "product_quantity": "7 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94271", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0437-2024", "product_description": "Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06", "product_quantity": "26,352 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240321", "center_classification_date": "20240405", "termination_date": "20250404", "report_date": "20240417", "code_info": "Lot #: A201064, Exp. Date March 2024"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0030-2025", "product_description": "Cinacalcet Tablets 30 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-440-10, b) 90 Tablets per bottle, NDC: 16729-440-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:             Expiry Date: M2118190        11/2024 M2201091        11/2024 M2206241             11/2024 M2206451             04/2025 M2208674             06/2025 M2213850             08/2025 M2215221             09/2025 M2216236             11/2025 M2217098             11/2025 M2300664             11/2025  b) Lot #:           Expiry Date: M2210808            06/2025 M2212212            08/2025 M2214435            09/2025 M2217097            11/2025 M2301921            01/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA213510"], "brand_name": ["DOCETAXEL"], "generic_name": ["DOCETAXEL ANHYDROUS"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-254"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOCETAXEL ANHYDROUS"], "rxcui": ["1093280"], "spl_id": ["841e3024-e160-4c4b-93d3-1e79d628d95b"], "spl_set_id": ["6b227144-c844-4549-960c-cc3ac5c13b2b"], "package_ndc": ["25021-254-08", "25021-254-16"], "is_original_packager": [true], "nui": ["N0000175085", "N0000175592"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "unii": ["699121PHCA"]}, "product_type": "Drugs", "event_id": "94707", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0553-2024", "product_description": "Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08", "product_quantity": "762 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.", "recall_initiation_date": "20240528", "center_classification_date": "20240612", "report_date": "20240619", "code_info": "Lot #: F1040001, Exp. Date 12/31/2024"}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0018-2025", "product_description": "Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58", "product_quantity": "1082 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038004, exp. date 27-Nov-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0524-2024", "product_description": "Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%),  Enriched with Capsaicin, Camphor, Menthol & MSM, Tube, NET WT 8 oz (226.79g), Made in the USA, painwizard.com  PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00011 6", "product_quantity": "7,410", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lots 19823C4, EXP 07/31/2025; 01623C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206241"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1191", "70710-1192", "70710-1193", "70710-1194", "70710-1195"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632"], "spl_id": ["51a2adf6-a381-42cb-bf3e-8c83a7cfe738"], "spl_set_id": ["839fe7ae-6835-4d6a-b6b1-ca7f062caa4f"], "package_ndc": ["70710-1191-1", "70710-1191-8", "70710-1192-1", "70710-1192-8", "70710-1193-1", "70710-1193-8", "70710-1194-1", "70710-1194-8", "70710-1195-1", "70710-1195-8"], "is_original_packager": [true], "upc": ["0370710119188", "0370710119485", "0370710119287"], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "94649", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0542-2024", "product_description": "Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8", "product_quantity": "21,360 units", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20240516", "center_classification_date": "20240606", "report_date": "20240612", "code_info": "Lot #: M310493, Exp. Date 01/2025; M308397, Exp. Date 11/2024; M305337, Exp. Date      10/2024; M400155, Exp. Date 06/2025; M314660, Exp. Date 05/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018565"], "brand_name": ["INFUMORPH 200"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6039", "0641-6040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INTRATHECAL"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["892652", "1731522", "1731998", "1731999"], "spl_id": ["cd3674c8-d894-4dcf-8044-7a1198ed8ed9"], "spl_set_id": ["db9ac9e3-d761-4a99-9f34-4946ebe8f255"], "package_ndc": ["0641-6039-01", "0641-6040-01"], "is_original_packager": [true], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "94208", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0392-2024", "product_description": "Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01", "product_quantity": "22,644 ampuls", "reason_for_recall": "The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.", "recall_initiation_date": "20240312", "center_classification_date": "20240321", "report_date": "20240327", "code_info": "Lot #:  052001, 052003, Exp. Date 11/2024; 023012, 023014, Exp. Date 08/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076784"], "brand_name": ["TRI-LO-SPRINTEC"], "generic_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2140"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["578732", "748797", "749155", "749156", "749157", "856467"], "spl_id": ["204ad27b-376e-4d07-bf27-1db57f446045"], "spl_set_id": ["ddbeb312-af2b-4d22-ab7c-5ab2f3f8d5cb"], "package_ndc": ["0093-2140-28", "0093-2140-62"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "94183", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0428-2024", "product_description": "Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62", "product_quantity": "92,676 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240307", "center_classification_date": "20240328", "termination_date": "20250306", "report_date": "20240403", "code_info": "Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93829", "recalling_firm": "IntegraDose Compounding Services LLC", "address_1": "719 Kasota Ave Se", "address_2": "N/A", "postal_code": "55414-2842", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MN only", "recall_number": "D-0258-2024", "product_description": "Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1", "product_quantity": "281 syringes", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240112", "center_classification_date": "20240122", "report_date": "20240131", "code_info": "Lot #: 20230921VAS-2, Exp. Date 03/19/2024"}, {"status": "Ongoing", "city": "Dania Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94788", "recalling_firm": "Little Moon Essentials LLC", "address_1": "501 Old Griffin Rd", "address_2": "N/A", "postal_code": "33004-2774", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Ontario, Canada (2 retailers)", "recall_number": "D-0573-2024", "product_description": "Little Moon Essentials, Aching Head Rub (Camphor 3.09%, Menthol 2.55%) , a) 0.5OZ (14G), metal tin, UPC Code 67367388226 8, NDC 70722-203-05; b)1OZ (28G) glass jar, UPC Code 6 73673 88203 9, NDC 70722-203-01; Little Moon Essentials LLC Dania Beach, Fl 33004", "product_quantity": "6,312 tin and glass jars", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240620", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "lot code No expiration date on product: a) 326070, 420140,  b) 322030, 321230, 329230, 321240, 329170, 328280, 326090, 322290, 327021, 323121, 327221, 429210, 424130, 427050"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-179", "55111-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["386ec98d-4a47-b025-b050-7e4ebce382c6"], "spl_set_id": ["a42f3479-f2c2-8214-d547-c5cae9bfed1e"], "package_ndc": ["55111-179-30", "55111-179-15", "55111-179-03", "55111-179-10", "55111-180-30", "55111-180-15", "55111-180-03", "55111-180-10"], "is_original_packager": [true], "upc": ["0355111180104", "0355111179108"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "93713", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0223-2024", "product_description": "Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15", "product_quantity": "38,952 bottles", "reason_for_recall": "Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.", "recall_initiation_date": "20240102", "center_classification_date": "20240111", "report_date": "20240117", "code_info": "Lot #: T2304007, Exp 7/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA215307"], "brand_name": ["DIGOXIN"], "generic_name": ["DIGOXIN"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["70954-200", "70954-201", "70954-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIGOXIN"], "rxcui": ["197604", "197606", "245273"], "spl_id": ["ee465d1a-f5ee-477b-b20e-3ce8705e7472"], "spl_set_id": ["dba3b3f7-3ff2-4996-8653-b0e54a398bf9"], "package_ndc": ["70954-201-10", "70954-201-20", "70954-202-10", "70954-202-20", "70954-200-10"], "is_original_packager": [true], "upc": ["0370954201106", "0370954201205", "0370954202103", "0370954200109"], "nui": ["N0000175568", "M0003451"], "pharm_class_epc": ["Cardiac Glycoside [EPC]"], "pharm_class_cs": ["Cardiac Glycosides [CS]"], "unii": ["73K4184T59"]}, "product_type": "Drugs", "event_id": "94255", "recalling_firm": "Novitium Pharma LLC", "address_1": "70 Lake Dr", "address_2": "", "postal_code": "08520-5321", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0443-2024", "product_description": "Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10", "product_quantity": "1,003 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240325", "center_classification_date": "20240413", "termination_date": "20240716", "report_date": "20240424", "code_info": "Lot M23011A; Exp. 12/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075478"], "brand_name": ["NORTREL 7/7/7"], "generic_name": ["NORETHINDRONE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["310463", "312033", "392662", "748797", "749852", "762007"], "spl_id": ["ddd9ebd7-bd21-4247-a158-95c5fc757aef"], "spl_set_id": ["992dcc56-90ab-4691-8114-16d47a8b9982"], "package_ndc": ["0555-9012-79", "0555-9012-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "93867", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0322-2024", "product_description": "Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58", "product_quantity": "19,824 cartons", "reason_for_recall": "Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.", "recall_initiation_date": "20240125", "center_classification_date": "20240212", "report_date": "20240221", "code_info": "Lot #: 100040731, Exp 7/31/2024"}, {"status": "Completed", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94519", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0602-2024", "product_description": "Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10", "product_quantity": "12,691 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240430", "center_classification_date": "20240716", "report_date": "20240724", "code_info": "Lot #: 8147040; Exp. June 2024 Lot #: 8163764; Exp. March 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Zug", "state": "N/A", "country": "Switzerland", "classification": "Class II", "openfda": {"application_number": ["ANDA212309"], "brand_name": ["FOSAPREPITANT"], "generic_name": ["FOSAPREPITANT"], "manufacturer_name": ["BE Pharmaceuticals Inc."], "product_ndc": ["71839-104"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["FOSAPREPITANT DIMEGLUMINE"], "rxcui": ["1731077"], "spl_id": ["1b1fe4ce-02d6-4ca1-8168-37b099caa434"], "spl_set_id": ["21b08b87-70e3-4233-9531-dd6d84eab5d0"], "package_ndc": ["71839-104-01"], "is_original_packager": [true], "upc": ["0371839104017"], "unii": ["D35FM8T64X"]}, "product_type": "Drugs", "event_id": "93747", "recalling_firm": "BE PHARMACEUTICALS AG", "address_1": "Bundesstrasse 3", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0262-2024", "product_description": "Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.", "product_quantity": "22,176 Vials", "reason_for_recall": "Lack of Sterility Assurance: Aseptic process simulation failure.", "recall_initiation_date": "20240110", "center_classification_date": "20240125", "termination_date": "20250610", "report_date": "20240131", "code_info": "lot #13D012AA, Exp: 08/31/2025"}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0522-2024", "product_description": "Bull Frog SPF 50 Amphibious Lotion SPF 50 Amphibious Lotion with Water Armor Tech, Broad Spectrum Sunscreen with UVA/UVB Protection, NEW WT. 5 FL OZ (148ML), Distributed by: Bullfrog Brands LLC, PO Box 600207, Dallas, TX 75360 USA. UPC 8 50016 52112 5", "product_quantity": "9,697", "reason_for_recall": "Out of Specification for active ingredient", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 08623C2, 08923C2, Exp 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7800"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807639"], "spl_id": ["318417ff-d599-47b8-8181-89c3bb3b2e8d"], "spl_set_id": ["47a0313f-36df-4fa6-a828-c9e1946ba9b0"], "package_ndc": ["0264-7800-09"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "95035", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 Mcgaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within U.S.A", "recall_number": "D-0638-2024", "product_description": "0.9% Sodium Chloride Injection USP, E8000, 1000mL container, Rx only, B. Braun Medical Inc., Irvine, CA, NDC 0264-7800-09.", "product_quantity": "63,444 containers", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20240724", "center_classification_date": "20240819", "report_date": "20240828", "code_info": "Lot #: J2L763, J2L764, Exp: 31 March 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0255-2024", "product_description": "Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Lavender, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-383-10, UPC: 0 37000 72986 0", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0057-2025", "product_description": "Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01", "product_quantity": "3139 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0050, exp. date 04/25/2026; 24A0055, exp. date 05/09/2026; 24A0059, exp. date 05/16/2026; 24A0060, exp. date 05/20/2026; 24A0071, exp. date 06/24/2026; 24A0072, exp. date 06/26/2026"}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Bryant Ranch Prepack"], "product_ndc": ["63629-9207"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309113"], "spl_id": ["f1e8edf5-5ad5-4e90-9f40-7b3a36df7f85"], "spl_set_id": ["e186afb5-7531-45ea-b785-c230483a7747"], "package_ndc": ["63629-9207-1"], "original_packager_product_ndc": ["67877-545"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "94605", "recalling_firm": "Bryant Ranch Prepack, Inc.", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0540-2024", "product_description": "Cephalexin for Oral Suspension, USP, 250mg/5mL, Rx only, 200mL (when mixed), Each contains cephalexin monohydrate, USP equivalent to 5g cephalexin. Manufactured by Alkem Laboratories Ltd, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9207-1.", "product_quantity": "61 Bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g'  instead of  Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g'", "recall_initiation_date": "20240510", "center_classification_date": "20240604", "report_date": "20240612", "code_info": "Lot: 235067, Exp 12/31/2025; 235289, Exp 11/30/2025; 235290, Exp 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077538"], "brand_name": ["FLUTICASONE PROPIONATE"], "generic_name": ["FLUTICASONE PROPIONATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0829"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["FLUTICASONE PROPIONATE"], "rxcui": ["1797907"], "spl_id": ["de4b94c3-9864-33f5-8afe-ec494562de52"], "spl_set_id": ["3830675d-b45e-fc97-1f73-674b1fc38c80"], "package_ndc": ["60505-0829-1"], "is_original_packager": [true], "unii": ["O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "93974", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0326-2024", "product_description": "Fluticasone Propionate Nasal Spray USP 50mcg,  120 Metered Sprays - 16 g net fill, Rx Only,  Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1", "product_quantity": "292,752 bottles", "reason_for_recall": "CGMP Deviations: potential presence of Burkholderia cepacia complex", "recall_initiation_date": "20240209", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "Lot number # TX5274 Exp. 09/30/2026"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95647", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "N/A", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0046-2025", "product_description": "Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution, Rx Only, Net Wt. 10 oz. (283.5 g) pumps, Mint flavor, Manufactured by: Keystone Industries, 480 S. Democrat Rd., Gibbstown, NJ 08027, NDC 68400-202-10", "product_quantity": "787 pumps", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20241017", "center_classification_date": "20241114", "report_date": "20241120", "code_info": "Lot #: PVC-003015, Exp. Date Sep-21-2025; PVC-003061, Exp. Date Apr-30-2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075682"], "brand_name": ["IBU"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-682", "55111-683", "55111-684"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807", "206905", "206913", "206917"], "spl_id": ["a7977972-4353-9ca0-d419-e37039010e7d"], "spl_set_id": ["24731405-219c-79b4-ecf0-7d5fbfda94ba"], "package_ndc": ["55111-682-09", "55111-682-01", "55111-682-05", "55111-683-30", "55111-683-50", "55111-683-09", "55111-683-01", "55111-683-05", "55111-684-30", "55111-684-50", "55111-684-60", "55111-684-09", "55111-684-01", "55111-684-05"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "95098", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0645-2024", "product_description": "IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a)NDC 55111-683-01 - 100 Tablets per bottle, b)NDC 5511-683-05 - 500 Tablets per bottle.", "product_quantity": "31,802 bottles", "reason_for_recall": "Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.", "recall_initiation_date": "20240806", "center_classification_date": "20240826", "report_date": "20240904", "code_info": "a)NDC 55111-683-01  Lots C2207527, Exp 5/31/2026; C2210864, Exp 9/30/2026; C2213018, Exp 11/30/2026.  b)NDC 5511-683-05  Lots C2207528, Exp 5/31/2026; C2210860, Exp 9/30/2026; C2213016, C2213017, Exp 11/30/2026; C2301852, C2302056, C2302057, Exp 1/31/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94553", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0519-2024", "product_description": "Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01", "product_quantity": "74,440 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot #: 23JUL025, Exp. Date 7/17/2024; 23SEP012, Exp. Date 7/11/2024; 23OCT015, Exp. Date 7/20/2024; 23OCT020, Exp. Date 7/25/2024; 23OCT026, Exp. Date 8/22/2024; 23NOV030, Exp. Date 8/29/2024, 23DEC026, Exp. Date 9/29/2024; 24JAN011, Exp. Date 7/21/2024;  24FEB033, Exp. Date 8/24/2024; 24JAN050, Exp. Date 8/30/2024", "more_code_info": ""}, {"status": "Completed", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204200"], "brand_name": ["ADRENALIN"], "generic_name": ["EPINEPHRINE", "EPINEPRINE"], "manufacturer_name": ["ENDO USA, Inc.", "Henry Schein, Inc."], "product_ndc": ["42023-159", "42023-168", "0404-9810"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["310132", "1490057", "1660014", "1660016"], "spl_id": ["ed8fb63a-8526-4e61-adb4-4da9d3d4f2a0", "d61797df-009f-4a42-ba7d-64fff2d7a321"], "spl_set_id": ["3b7a4364-668d-4eb2-a20c-04adc35aabe4", "b293ad8e-7055-4a95-a130-9d7d74f19eab"], "package_ndc": ["42023-159-01", "42023-159-25", "42023-168-01", "0404-9810-01"], "is_original_packager": [true], "upc": ["0342023168016"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"], "original_packager_product_ndc": ["42023-159"]}, "product_type": "Drugs", "event_id": "93839", "recalling_firm": "Henry Schein Inc. and Glove Club HSI Gloves Inc.", "address_1": "135 Duryea Rd", "address_2": "N/A", "postal_code": "11747-3834", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0342-2024", "product_description": "Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial, Rx only, Packaged By: Henry Schein, Inc., 80 Summit View Lane, Bastian, VA 24314, Original NDC 42023-159-25 Repack NDC 0404-9810-01", "product_quantity": "1,099 Single Dose Vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.", "recall_initiation_date": "20240117", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Original Lot # 64103, exp. date 11/24 Repackaged Lot # 39747, exp. date 01/26"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0106-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ", "product_quantity": "122,925 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) 30s; DT3023019A, exp. date Jan-25 DT3023050A, exp. date Apr-25;  b) 90s; DT3023022A, exp. date Jan-25;  c) 1000s; DT3022108A, DT3022107A, DT3022106A, DT3022111A, DT3022109A, exp. date Nov-24, DT3023001A, DT3023003A, exp. date Dec-24, DT3023024A, DT3023020B, exp. date Jan-25 DT3023027A, DT3023028A, exp. date Feb-25, DT3023034A, exp. date Mar-25, DT3023049A, exp. date Apr-25, DT3023095A, exp. date Jul-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0087-2025", "product_description": "MAXIM Assure Antibacterial,  Chloroxylenol 0.1%, Net Contents: One U.S. Gallon (3.78 L), For Industrial and Institutional Use Only, MIDLAB 140 Private Brand Way, Athens, TN 37303", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210464"], "brand_name": ["SEVELAMER CARBONATE FOR ORAL SUSPENSION"], "generic_name": ["SEVELAMER CARBONATE FOR ORAL SUSPENSION"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-478", "43598-479"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SEVELAMER CARBONATE"], "rxcui": ["861370", "861375"], "spl_id": ["85e37025-d239-e504-38a0-c2db7ffa0100"], "spl_set_id": ["de172c3d-17eb-3489-35fb-370a0893b663"], "package_ndc": ["43598-478-01", "43598-478-90", "43598-479-01", "43598-479-90"], "is_original_packager": [true], "unii": ["9YCX42I8IU"]}, "product_type": "Drugs", "event_id": "94884", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0625-2024", "product_description": "Sevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets per container, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India NDC 43598-478-90", "product_quantity": "5,136 cartons", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets", "recall_initiation_date": "20240626", "center_classification_date": "20240802", "report_date": "20240814", "code_info": "Lot #: T2305999, Exp. Date 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040796"], "brand_name": ["FOLIC ACID"], "generic_name": ["FOLIC ACID"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOLIC ACID"], "rxcui": ["310410"], "spl_id": ["92322e52-3179-4738-8c8a-14fef62311d4"], "spl_set_id": ["1ba8c407-9613-4319-ac40-0a429cb0f3f4"], "package_ndc": ["69315-127-01", "69315-127-10"], "is_original_packager": [true], "unii": ["935E97BOY8"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0183-2024", "product_description": "FOLIC ACID TABLETS, USP, 1MG, 100 Tablets per bottle, Rx Only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004.  NDC: 69315-127-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch H08221", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040074"], "brand_name": ["PROPARACAINE HYDROCHLORIDE"], "generic_name": ["PROPARACAINE HYDROCHLORIDE"], "manufacturer_name": ["Bausch & Lomb Incorporated"], "product_ndc": ["24208-730"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["PROPARACAINE HYDROCHLORIDE"], "rxcui": ["1191013"], "spl_id": ["46f24726-30f8-471b-b0be-b7da62d88bfc"], "spl_set_id": ["b699f838-8b69-4bac-953b-ea8822ec19fc"], "package_ndc": ["24208-730-06"], "is_original_packager": [true], "unii": ["U96OL57GOY"]}, "product_type": "Drugs", "event_id": "95333", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two medical facilities in MD and VA.", "recall_number": "D-0661-2024", "product_description": "Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06", "product_quantity": "27 bottles", "reason_for_recall": "Temperature abuse: Products exposed to improper temperature above drug label specifications.", "recall_initiation_date": "20240911", "center_classification_date": "20240920", "termination_date": "20250129", "report_date": "20241002", "code_info": "Lot # 476261, 479751, 479741, Exp 3/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0125-2025", "product_description": "Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "63,077 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8177078, Exp. Date May 2025; 8168596, Exp. Date Jan 2025 b) 3199313, Exp. Date May 2025; 3194118, Exp. Date Mar 2025; 3186238, Exp. Date Dec 2024; 3209590, Exp. Date Sep 2025; 3199317, Exp. Date May 2025; 3188733, Exp. Date Jan 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214554"], "brand_name": ["FOSFOMYCIN TROMETHAMINE"], "generic_name": ["FOSFOMYCIN TROMETHAMINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-749"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOSFOMYCIN TROMETHAMINE"], "rxcui": ["808917"], "spl_id": ["f6a079bc-179c-46e4-9077-96168cdd1cf9"], "spl_set_id": ["48e352bc-52ea-4778-905a-60ef38a5c18a"], "package_ndc": ["67877-749-57"], "is_original_packager": [true], "unii": ["7FXW6U30GY"]}, "product_type": "Drugs", "event_id": "93816", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0339-2024", "product_description": "Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC. Parsippany, NJ 07054. NDC 67877-749-57", "product_quantity": "71,244 sachets", "reason_for_recall": "Failed Impurities/Degradation Specification: Out of specification for organic impurities", "recall_initiation_date": "20240116", "center_classification_date": "20240220", "report_date": "20240228", "code_info": "lOTS #: 22121458, 22121459, 22121460, 22121461, 22121462, 22121463, 22121464, Exp 4/2024; 22121176, 22121407, 22121465, Exp 3/2024; 22121761, 22121762, 22121763, 22121764, 22121766, 22121968, 22121969, Exp 5/2024."}, {"status": "Completed", "city": "Ann Arbor", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA211617"], "brand_name": ["NEXLIZET"], "generic_name": ["BEMPEDOIC ACID AND EZETIMIBE"], "manufacturer_name": ["Esperion Therapeutics, Inc."], "product_ndc": ["72426-818"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BEMPEDOIC ACID", "EZETIMIBE"], "spl_id": ["ded66e40-dc19-4b24-ad70-cdcafb34d901"], "spl_set_id": ["3fa2108c-0300-47b8-9d34-f762af7c93c6"], "package_ndc": ["72426-818-03", "72426-818-09", "72426-818-99"], "is_original_packager": [true], "nui": ["N0000193913", "N0000193914", "N0000008553", "N0000175911"], "pharm_class_epc": ["Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["1EJ6Z6Q368", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "94365", "recalling_firm": "Esperion", "address_1": "3891 Ranchero Dr Ste 150", "address_2": "", "postal_code": "48108-2837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0441-2024", "product_description": "NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03", "product_quantity": "3,480 30-count bottles", "reason_for_recall": "Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.", "recall_initiation_date": "20240327", "center_classification_date": "20240412", "report_date": "20240424", "code_info": "Lot #,  1990305, Exp 08-31-2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0550-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 60 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-02", "product_quantity": "2,886 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: X025346, Exp 3/3/2025"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA215338"], "brand_name": ["VANCOMYCIN HYDROCHLORIDE"], "generic_name": ["VANCOMYCIN HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-2261"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VANCOMYCIN HYDROCHLORIDE"], "rxcui": ["2000134"], "spl_id": ["4709fe67-0ab3-4727-950f-b926a7bb21df"], "spl_set_id": ["3c47d5c4-8cdb-4701-8d7a-8a6e79025b53"], "package_ndc": ["69238-2261-3", "69238-2261-7", "69238-2261-5"], "is_original_packager": [true], "upc": ["0369238226157", "0369238226133", "0369238226171"], "unii": ["71WO621TJD"]}, "product_type": "Drugs", "event_id": "94262", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0442-2024", "product_description": "Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 150 mL bottle, NDC 69238-2261-7; (c)300 mL bottle,  NDC 69238-2261-5; Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807", "product_quantity": "821 bottles", "reason_for_recall": "Superpotent Drug:  Due to overfilling of drug powder", "recall_initiation_date": "20240321", "center_classification_date": "20240412", "termination_date": "20250721", "report_date": "20240424", "code_info": "Lot # (a) 22613003A, Exp. date 09/30/2025; (b) 22613004A, 22613005A, Exp. date 09/30/2025; (c) 22613005B, Exp. date 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Exton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95190", "recalling_firm": "ProRx LLC", "address_1": "619 Jeffers Cir", "address_2": "", "postal_code": "19341-2540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0653-2024", "product_description": "SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04", "product_quantity": "1,960 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240822", "center_classification_date": "20240905", "report_date": "20240911", "code_info": "ProRx061424, BUD 12/13/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95611", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0044-2025", "product_description": "Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90", "product_quantity": "N/A", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.", "recall_initiation_date": "20241023", "center_classification_date": "20241112", "report_date": "20241120", "code_info": "Lot# NB240873, Exp 03/31/2026"}, {"status": "Ongoing", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95659", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0056-2025", "product_description": "Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-104-01", "product_quantity": "7488 boxes", "reason_for_recall": "cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.", "recall_initiation_date": "20241111", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot# 24A0052, exp. date 05/01/2026; 24A0057, exp. date 05/13/2026; 24A0066, exp. date 05/31/2026; 24A0067, exp. date 06/04/2026; 24A0068, exp. date 06/17/2026; 24A0069, exp. date 06/19/2026 24A0075, exp. date 07/08/2026 24A0078, exp. date 07/12/2026"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209954"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-963"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123072"], "spl_id": ["ca017981-2752-46e0-9a66-418535597d31"], "spl_set_id": ["973b8686-c6ce-4280-85c4-c1e7ceab3c09"], "package_ndc": ["68180-963-01"], "is_original_packager": [true], "upc": ["0368180963011"], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0163-2024", "product_description": "ALBUTEROL SULFATE IN 90MCG per actuation, 200 Metered Inhalations, Rx Only, 8.5 g Net Contents, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India.  NDC: 68180-963-01", "product_quantity": "11 cartons", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch K100715", "more_code_info": ""}, {"status": "Ongoing", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94838", "recalling_firm": "GLOBAL WIDGET LLC", "address_1": "8419 Sunstate St", "address_2": "", "postal_code": "33634-1306", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0616-2024", "product_description": "Hemp Bombs CBD Pain Freeze (menthol 4%), 1000mg, 4 oz  bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634; UPC Code: 8-40078-56612-7", "product_quantity": "2082 bottles", "reason_for_recall": "Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.", "recall_initiation_date": "20240625", "center_classification_date": "20240722", "report_date": "20240731", "code_info": "Lot #: 220365, Exp date Oct 2024 ; 230090, Exp. date Feb 2025", "more_code_info": ""}]